Psychotherapy may change memories of childhood—here’s why practitioners should warn clients

One of the unfortunate legacies that my generation, gen X, has passed on to the millennials and gen Z, is the idea that therapy has no side effects. However, just like many other medical treatments, there can be negative effects. For example, in some cases psychotherapy can be linked with a worsening of psychiatric symptoms, increased anxiety and false memories.

Smartwatches may soon detect congestive heart failure

Researchers at Tampere University have achieved a major milestone in diagnosing heart diseases. According to their new study published in Heart Rhythm O2, congestive heart failure can be reliably detected by analyzing the intervals between successive heartbeats—inter-beat or RR intervals—which can be measured not only with professional equipment but also with smartwatches and heart rate monitors.

Cystic fibrosis alters immune system from early life stages, researchers discover

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the disease causes changes in the immune system early in life, presumably even in newborns. These changes lead to frequent inflammation and are not affected by drugs targeting the altered mucus production.

AI and neural networks can reduce wait times for lesion classification in breast cancer patients

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting to get test results back, waiting to learn the outcome of treatment protocols. A new paper published in Scientific Reports evaluates the use of artificial intelligence (AI) and neural networks to significantly cut the time required for medical professionals to classify lesions in breast cancer ultrasound images.

The two proteins involved in Alzheimer’s disease affect brain circuits differently, study shows

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the two key pathological hallmarks of Alzheimer’s—tau protein and beta-amyloid—affect brain circuits in distinct yet synergistic ways, particularly those linked to memory and emotions. The study, using a new animal model of Alzheimer’s disease, suggests a potential breakthrough in treatment strategies.